This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Moderna Inc. (MRNA) advanced 1.98% to $311.13 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index falling 0.14% to 14,465.92 and Dow Jones Industrial Average falling 0.34% to 34,378.34. This was the stock's second consecutive day of gains. Moderna Inc. closed $186.36 short of its 52-week high ($497.49), which the company achieved on August 10th.
The stock outperformed some of its competitors Tuesday, as AbbVie Inc. (ABBV) fell 1.60% to $108.57, Amgen Inc. (AMGN) fell 2.33% to $201.89, and AstraZeneca PLC ADR (AZN.LN) fell 0.87% to $60.27. Trading volume (10.2 M) remained 7.3 million below its 50-day average volume of 17.5 M.
Data source: Dow Jones Market Data, FactSet. Data compiled October 12, 2021.
(END) Dow Jones Newswires
October 12, 2021 16:31 ET (20:31 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.